No datasets match
- curatedBreastData::curatedBreastData_pDatacuratedBreastData_pData
- curatedCRCData::GSE11237_esetCelecoxib pre-treatment in human colorectal adenocarcinoma patients is associated with gene expression alterations suggestive of diminished cellular proliferation.
- curatedCRCData::GSE12225.GPL3676_esetIntegrating chromosomal aberrations and gene expression profiles to dissect rectal tumorigenesis.
- curatedCRCData::GSE12945_esetAn expression module of WIPF1-coexpressed genes identifies patients with favorable prognosis in three tumor types.
- curatedCRCData::GSE13067_esetDNA copy-number alterations underlie gene expression differences between microsatellite stable and unstable colorectal cancers.
- curatedCRCData::GSE13294_esetDNA copy-number alterations underlie gene expression differences between microsatellite stable and unstable colorectal cancers.
- curatedCRCData::GSE14095_esetGene expression signature and response to the use of leucovorin, fluorouracil and oxaliplatin in colorectal cancer patients.
- curatedCRCData::GSE14333_esetMetastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer.
- curatedCRCData::GSE16125.GPL5175_esetIntegrative approach for prioritizing cancer genes in sporadic colon cancer.
- curatedCRCData::GSE17536_esetExperimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer.
- curatedCRCData::GSE17537_esetExperimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer.
- curatedCRCData::GSE17538.GPL570_esetExperimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer.
- curatedCRCData::GSE18105_esetMUC12 mRNA expression is an independent marker of prognosis in stage II and stage III colorectal cancer.
- curatedCRCData::GSE2109_esetExpression Project for Oncology (expO)
- curatedCRCData::GSE21510_esetClinical significance of osteoprotegerin expression in human colorectal cancer.
- curatedCRCData::GSE21815_esetLong noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers.
- curatedCRCData::GSE24549.GPL5175_esetTranscriptome instability in colorectal cancer identified by exon microarray analyses: Associations with splicing factor expression levels and patient survival.
- curatedCRCData::GSE24550.GPL5175_esetTranscriptome instability in colorectal cancer identified by exon microarray analyses: Associations with splicing factor expression levels and patient survival.
- curatedCRCData::GSE2630_esetA gene signature of 8 genes could identify the risk of recurrence and progression in Dukes' B colon cancer patients.
- curatedCRCData::GSE26682.GPL570_esetMRE11 deficiency increases sensitivity to poly(ADP-ribose) polymerase inhibition in microsatellite unstable colorectal cancers.
- curatedCRCData::GSE26682.GPL96_esetMRE11 deficiency increases sensitivity to poly(ADP-ribose) polymerase inhibition in microsatellite unstable colorectal cancers.
- curatedCRCData::GSE26906_esetExpression Profiles in Stage II Colon Cancer According to APC Gene Status.
- curatedCRCData::GSE27544_esetGenome-wide profiling characterizes CRCs with genetic instability and specific routes to HLA class I loss and immunoescape
- curatedCRCData::GSE28702_esetPotential responders to FOLFOX therapy for colorectal cancer by Random Forests analysis.
- curatedCRCData::GSE3294_esetComparative study of gene expression by cDNA microarray in human colorectal cancer tissues and normal mucosa.
- curatedCRCData::GSE33113_esetMutations in the Ras-Raf Axis underlie the prognostic value of CD133 in colorectal cancer.
- curatedCRCData::GSE39582_esetGene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value.
- curatedCRCData::GSE3964_esetDeciphering cellular states of innate tumor drug responses.
- curatedCRCData::GSE4045_esetSerrated carcinomas form a subclass of colorectal cancer with distinct molecular basis.
- curatedCRCData::GSE4526_esetGene expression signature for recurrence in stage III colorectal cancers.
- curatedCRCData::GSE45270_esetAMC tubular and serrated adenomas
- curatedCRCData::TCGA.COAD_esetComprehensive molecular characterization of human colon and rectal cancer.
- curatedCRCData::TCGA.READ_esetComprehensive molecular characterization of human colon and rectal cancer.
- curatedCRCData::TCGA.RNASeqV2_esetComprehensive molecular characterization of human colon and rectal cancer.
- curatedCRCData::TCGA.RNASeqV2.READ_esetComprehensive molecular characterization of human colon and rectal cancer.
- curatedMetagenomicData::sampleMetadataManually Curated Sample Metadata
- curatedMetagenomicData::sampleMetadataManually Curated Sample Metadata
- curatedOvarianData::E.MTAB.386_esetAngiogenic mRNA and microRNA gene expression signature predicts a novel subtype of serous ovarian cancer.
- curatedOvarianData::GSE12418_esetExpression analysis of stage III serous ovarian adenocarcinoma distinguishes a sub-group of survivors.
- curatedOvarianData::GSE12470_esetGene expression profiling of advanced-stage serous ovarian cancers distinguishes novel subclasses and implicates ZEB2 in tumor progression and prognosis.
- curatedOvarianData::GSE13876_esetSurvival-related profile, pathways, and transcription factors in ovarian cancer.
- curatedOvarianData::GSE14764_esetA prognostic gene expression index in ovarian cancer - validation across different independent data sets.
- curatedOvarianData::GSE17260_esetGene expression profile for predicting survival in advanced-stage serous ovarian cancer across two independent datasets.
- curatedOvarianData::GSE18520_esetA gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2.
- curatedOvarianData::GSE19829.GPL570_esetGene expression profile of BRCAness that correlates with responsiveness to chemotherapy and with outcome in patients with epithelial ovarian cancer.
- curatedOvarianData::GSE19829.GPL8300_esetGene expression profile of BRCAness that correlates with responsiveness to chemotherapy and with outcome in patients with epithelial ovarian cancer.
- curatedOvarianData::GSE20565_esetA genomic and transcriptomic approach for a differential diagnosis between primary and secondary ovarian carcinomas in patients with a previous history of breast cancer.
- curatedOvarianData::GSE2109_esetIGC EXpression Project for Oncology
- curatedOvarianData::GSE26193_esetmiR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response.
- curatedOvarianData::GSE26712_esetA gene signature predicting for survival in suboptimally debulked patients with ovarian cancer.
- curatedOvarianData::GSE30009_esetMultidrug resistance-linked gene signature predicts overall survival of patients with primary ovarian serous carcinoma.
- curatedOvarianData::GSE30161_esetMulti-gene expression predictors of single drug responses to adjuvant chemotherapy in ovarian carcinoma: predicting platinum resistance.
- curatedOvarianData::GSE32062.GPL6480_esetHigh-risk ovarian cancer based on 126-gene expression signature is uniquely characterized by downregulation of antigen presentation pathway.
- curatedOvarianData::GSE32063_esetHigh-risk ovarian cancer based on 126-gene expression signature is uniquely characterized by downregulation of antigen presentation pathway.
- curatedOvarianData::GSE44104_esetCOL11A1 promotes tumor progression and predicts poor clinical outcome in ovarian cancer.
- curatedOvarianData::GSE49997_esetValidating the impact of a molecular subtype in ovarian cancer on outcomes: a study of the OVCAD Consortium.
- curatedOvarianData::GSE51088_esetPOSTN/TGFBI-associated stromal signature predicts poor prognosis in serous epithelial ovarian cancer.
- curatedOvarianData::GSE6008_esetLysophosphatidic acid-induced transcriptional profile represents serous epithelial ovarian carcinoma and worsened prognosis.
- curatedOvarianData::GSE6822_esetClassification of ovarian tumor samples
- curatedOvarianData::GSE8842_esetAnalysis of gene expression in early-stage ovarian cancer.
- curatedOvarianData::GSE9891_esetNovel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome.
- curatedOvarianData::PMID15897565_esetPatterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers.
- curatedOvarianData::PMID17290060_esetAn integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer.
- curatedOvarianData::PMID19318476_esetMicroarray analysis of early stage serous ovarian cancers shows profiles predictive of favorable outcome.
- curatedOvarianData::TCGA_esetIntegrated genomic analyses of ovarian carcinoma.
- curatedOvarianData::TCGA.mirna.8x15kv2_esetIntegrated genomic analyses of ovarian carcinoma.
- curatedOvarianData::TCGA.RNASeqV2_esetIntegrated genomic analyses of ovarian carcinoma.
- curatedOvarianData::E.MTAB.386_esetAngiogenic mRNA and microRNA gene expression signature predicts a novel subtype of serous ovarian cancer.
- curatedOvarianData::GSE12418_esetExpression analysis of stage III serous ovarian adenocarcinoma distinguishes a sub-group of survivors.
- curatedOvarianData::GSE12470_esetGene expression profiling of advanced-stage serous ovarian cancers distinguishes novel subclasses and implicates ZEB2 in tumor progression and prognosis.
- curatedOvarianData::GSE13876_esetSurvival-related profile, pathways, and transcription factors in ovarian cancer.
- curatedOvarianData::GSE14764_esetA prognostic gene expression index in ovarian cancer - validation across different independent data sets.
- curatedOvarianData::GSE17260_esetGene expression profile for predicting survival in advanced-stage serous ovarian cancer across two independent datasets.
- curatedOvarianData::GSE18520_esetA gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2.
- curatedOvarianData::GSE19829.GPL570_esetGene expression profile of BRCAness that correlates with responsiveness to chemotherapy and with outcome in patients with epithelial ovarian cancer.
- curatedOvarianData::GSE19829.GPL8300_esetGene expression profile of BRCAness that correlates with responsiveness to chemotherapy and with outcome in patients with epithelial ovarian cancer.
- curatedOvarianData::GSE20565_esetA genomic and transcriptomic approach for a differential diagnosis between primary and secondary ovarian carcinomas in patients with a previous history of breast cancer.
- curatedOvarianData::GSE2109_esetIGC EXpression Project for Oncology
- curatedOvarianData::GSE26193_esetmiR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response.
- curatedOvarianData::GSE26712_esetA gene signature predicting for survival in suboptimally debulked patients with ovarian cancer.
- curatedOvarianData::GSE30009_esetMultidrug resistance-linked gene signature predicts overall survival of patients with primary ovarian serous carcinoma.
- curatedOvarianData::GSE30161_esetMulti-gene expression predictors of single drug responses to adjuvant chemotherapy in ovarian carcinoma: predicting platinum resistance.
- curatedOvarianData::GSE32062.GPL6480_esetHigh-risk ovarian cancer based on 126-gene expression signature is uniquely characterized by downregulation of antigen presentation pathway.
- curatedOvarianData::GSE32063_esetHigh-risk ovarian cancer based on 126-gene expression signature is uniquely characterized by downregulation of antigen presentation pathway.
- curatedOvarianData::GSE44104_esetCOL11A1 promotes tumor progression and predicts poor clinical outcome in ovarian cancer.
- curatedOvarianData::GSE49997_esetValidating the impact of a molecular subtype in ovarian cancer on outcomes: a study of the OVCAD Consortium.
- curatedOvarianData::GSE51088_esetPOSTN/TGFBI-associated stromal signature predicts poor prognosis in serous epithelial ovarian cancer.
- curatedOvarianData::GSE6008_esetLysophosphatidic acid-induced transcriptional profile represents serous epithelial ovarian carcinoma and worsened prognosis.
- curatedOvarianData::GSE6822_esetClassification of ovarian tumor samples
- curatedOvarianData::GSE8842_esetAnalysis of gene expression in early-stage ovarian cancer.
- curatedOvarianData::GSE9891_esetNovel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome.
- curatedOvarianData::PMID15897565_esetPatterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers.
- curatedOvarianData::PMID17290060_esetAn integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer.
- curatedOvarianData::PMID19318476_esetMicroarray analysis of early stage serous ovarian cancers shows profiles predictive of favorable outcome.
- curatedOvarianData::TCGA_esetIntegrated genomic analyses of ovarian carcinoma.
- curatedOvarianData::TCGA.mirna.8x15kv2_esetIntegrated genomic analyses of ovarian carcinoma.
- curatedOvarianData::TCGA.RNASeqV2_esetIntegrated genomic analyses of ovarian carcinoma.
- HMP16SData::dictionaryA data dictionary describing dbGaP metadata variables
- HMP16SData::dictionaryA data dictionary describing dbGaP metadata variables
- lefser::zeller14Example dataset for lefser
- lefser::zeller14Example dataset for lefser
- MicrobiomeBenchmarkData::sampleMetadatasampleMetadata
- MicrobiomeBenchmarkData::sampleMetadatasampleMetadata
- MultiAssayExperiment::miniACCAdrenocortical Carcinoma (ACC) MultiAssayExperiment
- MultiAssayExperiment::miniACCAdrenocortical Carcinoma (ACC) MultiAssayExperiment
- TCGAutils::clinicalNamesClinical dataset names in TCGA
- TCGAutils::diseaseCodesTCGA Cancer Disease Codes Table
- TCGAutils::sampleTypesBarcode Sample Type Table
- TCGAutils::clinicalNamesClinical dataset names in TCGA
- TCGAutils::diseaseCodesTCGA Cancer Disease Codes Table
- TCGAutils::sampleTypesBarcode Sample Type Table